Nature Search

Reflections on science advisory systems in Canada

Remi Quirion
Arthur Carty
Ramia Jabr
ResearchOpen Access02 Aug 2016
Palgrave Communications

Volume: 2, P: 1-10
Never too local for science advice

No government is too small to promote data-informed decisions and innovation. This is especially true for cities, argues Rémi Quirion.

Rémi Quirion
Comments & Opinion31 Jul 2024
Nature Cities

Volume: 1, P: 494
Autoradiographic distribution of substance P receptors in rat central nervous system

Remi Quirion
Clifford W. Shults
Thomas L. O'Donohue
Research01 Jun 1983
Nature

Volume: 303, P: 714-716
Reduction in Acetylcholine Release in the Hippocampus of Dopamine D5 Receptor-Deficient Mice

François Laplante
David R Sibley
Rémi Quirion
Research21 Apr 2004
Neuropsychopharmacology

Volume: 29, P: 1620-1627
Scientific diplomacy keeps reason alight in dark times

Peter Gluckman
Rémi Quirion
Albert S. van Jaarsveld
Correspondence19 Apr 2022
Nature

Volume: 604, P: 425
Alterations in Behavioral Responses to a Cholinergic Agonist in Post-Pubertal Rats with Neonatal Ventral Hippocampal Lesions: Relationship to Changes in Muscarinic Receptor Levels

François Laplante
Osamu Nakagawasai
Rémi Quirion
Research22 Dec 2004
Neuropsychopharmacology

Volume: 30, P: 1076-1087
International perspectives on engaging the public in neuroethics

Judy Illes
Colin Blakemore
Piergiorgio Strata
Comments & Opinion01 Dec 2005
Nature Reviews Neuroscience

Volume: 6, P: 977-982
The Neuropeptide Y (NPY) Y1 Receptor Subtype Mediates NPY-induced Antidepressant-like Activity in the Mouse Forced Swimming Test

John P Redrobe
Yvan Dumont
Rémi Quirion
Research08 Nov 2001
Neuropsychopharmacology

Volume: 26, P: 615-624
Erratum: Reflections on science advisory systems in Canada

Remi Quirion
Arthur Carty
Ramia Jabr
Amendments and CorrectionsOpen Access13 Sept 2016
Palgrave Communications

Volume: 2, P: 1
Securing the future of drug discovery for central nervous system disorders

Innovative partnerships among researchers, patients, regulators, payors and industry are needed to reinvigorate drug discovery for central nervous system disorders. Here, representatives of the 2013 Collegium Internationale Neuro-Psychopharmacologicum (CINP) Summit group summarize plans to achieve this goal.

Peter Høngaard Andersen
Richard Moscicki
Anthony Phillips
Comments & Opinion01 Dec 2014
Nature Reviews Drug Discovery

Volume: 13, P: 871-872
High Resolution Dissection of Reactive Glial Nets in Alzheimer’s Disease

David S. Bouvier
Emma V. Jones
Keith K. Murai
ResearchOpen Access19 Apr 2016
Scientific Reports

Volume: 6, P: 1-15

Search

Filter By:

Search

Quick links